Sami Uwaydat, MD
Ophthalmology · Little Rock, ARNPI 1679798698
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,430 of the $3,616 with a category attached, or 67.2%. Genentech USA, Inc. accounts for 67.2% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $2,430, more than ten times the $19 reported in 2020. Among ophthalmology clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 3 payments — averaging $1205.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$2K
- Optos, Inc.$1K
- Carl Zeiss Meditec AG$19
Across 6 payments — averaging $3512.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$21K
What the payments were for
- Consulting fees$2,43067%
- Gifts$191%
- Other$1,16732%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 1 | $2,430 |
| Optos, Inc. | 1 | $1,167 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VABYSMO$2,430
- PANORAMIC OPHTHALMOSCOPE$1,167
How this compares
$3,616 in reported general payments places this provider in the 90th percentile of 125 ophthalmology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 73 | $2,071 |
| Ketorolac Tromethamine | 56 | $830 |
| Brimonidine Tartrate | 27 | $524 |
| Dorzolamide Hcl | 26 | $347 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 24 | $292 |
| Timolol Maleate | 18 | $193 |
| Prednisone | 12 | $37 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Little Rock
- Jennifer DoyleLittle Rock$38K
- Jonathan CascianoLittle Rock$4K
- Christian HesterLittle Rock$4K
- Daniel KimLittle Rock$2K
- Justin LieblongLittle Rock$2K
- Kent ZocchiLittle Rock$2K
- Lydia LaneLittle Rock$2K
- Richard MorshediLittle Rock$2K
- Susan BlairLittle Rock$2K
- Tom KornhauserLittle Rock$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.